Volume : 10, Issue : 01, January – 2023



Authors :

J S Venkatesh, Upendra N, Devi Dileep, Jeena M Jacob, Jeeshna Jayan, Josy Varghese

Abstract :

Plants are natural remedies and have been used as food and medicine by humans on earth since ancient times. Today there are efforts to find herbal medicines in plants in order to bring them to market through a drug delivery system suitable for humanity. The basics idea behind it is that the cure for every disease is hidden in nature. However, herbal drug delivery also requires modifications with the purpose to achieve sustained release, increase patient compliance, etc. So far, herbal medicines have failed to attract scientist’s changes to new drug delivery systems due to difficulties in processing, standardization, extraction, and identification. But now days with the technological advances, new drug delivery systems (NDDS) open the door to the development of new herbal medicines system. Using advanced techniques to protect against toxicity, enhance stability, improve bioavailability of herbal formulations, protection against physical and chemical degradation can be achieved. New drug delivery technologies have gained prominence to achieve the modified release of herbal medicines to increases their therapeutic value and decreases their toxicity. Current ratings provide insight on various new techniques used to improve the safety and efficacy of phytomedicines and the application of new formulations. The most important goal for developing such delivery systems is to minimize drug degradation and loss, and to prevent and increase harmful side effects biological availability. Targeting is the ability to direct the drug-laden system to the location of interest. Among the drug carriers there are solubles polymers, micro particles consisting of insoluble (or) biodegradable natural and synthetic polymers, microcapsules, cells, ghost cells, lipoproteins, liposomes and micelles. Two main mechanisms can be distinguished for targeting the desired drug delivery sites, (a) passively and (b) Active targeting. Controlled drug delivery systems, such as micellar solutions, vesicles and liquid crystal dispersions, as well as nanoparticles Dispersions consisting of small particles of 10-400 nm are promising as drug delivery systems. Hydrogels are three-dimensional, hydrophilic polymer networks capable of absorbing large quantities of water or biological fluids.
Key words: Novel drug delivery system, Phytosome, Nanoparticle, Microsphere, Transdermal drug delivery system carrier, Colloidal drug delivery system

Cite This Article:

Please cite this article in press J S Venkatesh et al, A Review On Novel Drug Delivery System: A Recent Trend., Indo Am. J. P. Sci, 2023; 10 (01).

Number of Downloads : 10


1. Cott J. Natural product formulations available in Europe for psychotropic indications. Psychopharmacol Bull, ; 199531:745.
2. Atram S. Recent development of herbal formulation-a novel drug delivery system. International Ayurvedic Medical Journal, 2014; 2(6):952-58.
3. Kumar K, Rai AK. Miraculous therapeutic effect of herbal drug using novel drug delivery system. International Research Journal of Pharmacy, 3(2), 2012, 27-30.
4. Musthaba S, Baboota S, Ahmed S, Ahuja A, Ali J. Status of novel drug delivery technology for phytotherapeutics. Expert opinion Drug delivery, 6(6), 2009, 625-37.8.
5. Muller RH, Runge SA. Solid lipid nanoparticles (SLN) for controlled drug delivery. In: Benita S, editor. Submicron emulsions in drug targeting and delivery. Harwood Academic Pub, 1998; 22(7):219-234.
6. Jain NK. Controlled and Novel drug delivery, 4th edition, New Delhi: CBS Publishers and Distributers, 2002, 236- 237.
7. Amin T, Bhat SV. A Review on Phytosome Technology as a Novel Approach to Improve the Bioavailability of Nutraceuticals. International Journal of Advancements in Research and Technology, 2012; 1(3):1-15.
8. Hikino H, Kiso Y, Wagner H, Fiebig M. Antihepatotoxic actions of flavonolignans from Silybummarianumfruits. Planta Med, 1984; 50:248-50.
9. Chaturvedi M, Kumar M, Sinhal A, AlimuddinSaifi. Recent development in novel drug delivery systems of herbal drugs. International journal of Green Pharmacy, 2011; 5:87-94.
10. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release, 2001; 70:1-20.
11. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro andnanoparticles in drug delivery. Journal of Controlled Release 2004; 100:5-28.
12. Jumaa M and Muller BW. Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: Mechanism of protective effect. Eur J Pharm Sci, 2009; 9:285-290.
13. Cui F, Wang Y, Wang J, Feng L, Ning K. Preparation of an entericsoluble solid-state emulsion using oily drugs. Int J Pharma, 2007; 338:152-6.
14. Rastogi V, Shukla S, Singh R, Lal N, Yadav P, Microspheres: A Promising Drug Carrier. Journal of Drug Delivery and Therapeutics, 2016; 6(3):18-26.
15. Jaiswal P, Kesharwani S, Kesharwani R, Patel D, Ethosome: A New Technology Used As Topical & Transdermal Delivery System. Journal of Drug Delivery and Therapeutics, 2016; 6(3):7-17.
16. Saupe, Anne; Rades, Thomas (2006). “Solid Lipid Nanoparticles”. Nanocarrier Technologies. p. 41. doi:10.1007/978-1-4020-5041-1_3. ISBN 978-1-4020-5040-4.
17. Jenning, V; Thünemann, AF; Gohla, SH. “Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids”. International Journal of Pharmaceutics. 2000; 199(2):167–77. PMID 10802410.
18. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation. Rawat MK, Jain A and Singh S, Journal of Pharmaceutical Sciences, 2011; 100(6):2366-2378
19. Hunter CA. Vesicular System (Niosomes and Liposomes) for Delivery of Sodium Stibogluconate in Experimental Murine Visceral Leishmaniasis. J Pharm Pharmacol, 1988, 161-164.30.
20. Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, and Piccerelle, P. Int.J. Pharm 2005; 292:1-2, 29-41.
21. Yoshio K, Masazumi K, Shuichi A, and Hiroaki N, J. Control. Release, 2005; 105(1-2):16-22.
22. Prajapati S, Maurya S, Das M, Tilak V, Verma K, & Dhakar R. Dendrimers in Drug Delivery, Diagnosis and Therapy: Basics and Potential Applications. Journal of Drug Delivery and Therapeutics, 2016; 6(1):67-92.
23. Muller Goymann CC. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Europ J of Pharmaceutics and Biopharmaceutics, 2004; 58(1):343-356.
24. Sood A and Panchagnula R. Peroral Route: An Opportunity for Protein and Peptide Drug Delivery.Chemical Reviews 2000; 101:3275-303.